ABG
KRRO icon

Ally Bridge Group’s Korro Bio KRRO Stock Holding History

Ally Bridge Group’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-154,223
Closed -$1.93M – 29
2025
Q2 		$1.93M Buy
154,223
+94,500
+158% +$1.36M 1.6% 20
2025
Q1 		$1.04M Sell
59,723
-10,955
-15% -$325K 0.94% 25
2024
Q4 		$2.69M Buy
+70,678
New +$3.63M 2.31% 17

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ally Bridge Group's KRRO Position: Q3 2025 in Review

Ally Bridge Group sold out of Korro Bio (KRRO) in Q3 2025, closing a stake of 154,223 shares — an estimated $1.93M sold.

Ally Bridge Group first reported a position in KRRO in Q4 2024 and held it in 3 quarters. The position peaked at $2.69M in Q4 2024. 92 funds tracked by Wall St. Rank hold KRRO as of Q3 2025.

  • Ally Bridge Group reported no remaining Korro Bio position as of Q3 2025 after selling out during the quarter.
  • Ally Bridge Group sold 154,223 Korro Bio shares in Q3 2025, an estimated $1.93M.
  • Ally Bridge Group first reported a position in Korro Bio in Q4 2024 and held it in 3 quarters.
  • Ally Bridge Group's Korro Bio position peaked at $2.69M in Q4 2024.
  • 92 funds tracked by Wall St. Rank held Korro Bio as of Q3 2025.

Based on Ally Bridge Group's 13F filing for Q3 2025, filed 14 Nov 2025.